Table 3.
Effects of EAE on the SOD activity and MDA, Hyp, Elastin, and moisture content in mice skin.
| Groupc | MDA (nmol/mg prot) | SOD (U/mg prot) | Hyp (mg/g) | Elastin (ng/mL) | Moisture (%) |
|---|---|---|---|---|---|
| Model | 15.93 ± 4.41 | 67.69 ± 16.24 | 1.08 ± 0.16 | 815.95 ± 52.67 | 66.63 ± 1.78 |
| Control | 8.76 ± 2.82b | 119.03 ± 13.55b | 4.89 ± 0.18b | 920.43 ± 61.73a | 75.47 ± 2.64b |
| VE | 5.48 ± 4.44b | 97.02 ± 5.78b# | 3.07 ± 0.30b## | 937.73 ± 63.53a | 70.95 ± 1.30b# |
| Low dose | 6.95 ± 2.13b | 66.96 ± 10.31B## | 2.43 ± 0.16bB## | 877.48 ± 97.44 | 68.05 ± 1.44A## |
| Medium dose | 6.34 ± 0.80b# | 84.32 ± 12.39## | 2.57 ± 0.35bA## | 892.24 ± 42.27a | 69.92 ± 1.59a# |
| High dose | 5.51 ± 2.67b# | 99.07 ± 11.74b# | 3.09 ± 0.27b## | 921.63 ± 34.24b | 70.93 ± 6.26 |
a P < 0.05; b P < 0.01 compared with model group (all groups).
A P < 0.05; B P < 0.01 compared with VE group (EAE groups).
# P < 0.05; ## P < 0.01 compared with control group (VC and EAE groups).
CVE group (1%); low dose EAE group (1%); medium dose EAE group (2%); and high dose EAE group (4%).